Results 111 to 120 of about 45,989 (185)

GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosis. [PDF]

Respir Res
Broens B, van der Laken CJ, Radonic T, Nossent EJ, Manz XD, Mulder DJ, Al-Adwi Y, Gan CT, Timens W, Voskuyl AE, Duitman JW.   +10 more
europepmc   +1 more source

TransplantLines, a biobank and cohort study of solid organ transplant recipients and donors. [PDF]

Eur J Epidemiol
Posthumus AM, Knobbe TJ, Kremer D, Gomes-Neto AW, Dielwart IJC, Jonker J, Doorenbos CSE, Eisenga MF, van Londen M, Douwes RM, Nieuwenhuis LM, Annema C, de Boer MT, de Borst MH, Damman K, Pol RA, Gan CT, Verschuuren EAM, Blokzijl H, de Meijer VE, Bakker SJL, TransplantLines Investigators.   +21 more
europepmc   +1 more source

Timing of lung transplant evaluation: considerations, barriers and alternatives. [PDF]

Curr Opin Pulm Med
van der Ploeg EA, Hylkema TH, Gan CT.
europepmc   +1 more source

Tremor, Daily Functioning, and Health-Related Quality of Life in Solid Organ Transplant Recipients. [PDF]

Transpl Int, 2023
Riemersma NL, Kremer D, Knobbe TJ, Gan CT, Nolte S, Gomes-Neto AW, Blokzijl H, de Meijer VE, Damman K, Eisenga MF, Drost G, Elting JWJ, Touw DJ, Berger SP, Bakker SJL, van der Stouwe AMM, Transplantlines Investigators.   +16 more
europepmc   +1 more source

Urinary endotrophin as a biomarker for T cell-mediated rejection-associated fibrogenesis in kidney transplant recipients. [PDF]

Clin Kidney J
Alkaff FF, Kremer D, Rasmussen DGK, Sparding N, Genovese F, Karsdal M, Dam WA, van den Heuvel MC, Tepel M, Thaunat O, TransplantLines Investigators , Berger SP, van den Born J, Bakker SJL.   +13 more
europepmc   +1 more source

Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction. [PDF]

Transpl Infect Dis
Gemert JPV, Fleurke GJ, Akkerman OW, Gan CT, Steenhuis WN, Kerstjens HAM, Verschuuren EAM, Postma DF.   +7 more
europepmc   +1 more source

Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing disease. [PDF]

RMD Open
Atzinger A, Tascilar K, Kleyer A, Hueber AJ, Schmidkonz C, Kuwert T, Beck M, Fagni F, Corte G, Ramming A, Schett G, Bayat S.   +11 more
europepmc   +1 more source

Evaluation of Elexacafor/Tezacaftor/Ivacaftor therapy after lung transplantation in Cystic Fibrosis: The Dutch National KOALA study. [PDF]

JHLT Open
KOALA study group, van Gemert JP, Luijk B, Hellemons ME, Visser KA, Hansen CME, van der Meer R, Gan CT, van der Vaart H, Akkerman OW, Steenhuis WN, Verkleij M, Heijerman HGM, Verschuuren EAM.   +13 more
europepmc   +1 more source

It takes two: Aberrant repair and low-grade inflammation characterize bronchiolitis obliterans syndrome after lung transplantation in serum proteomic analysis. [PDF]

JHLT Open
van der Ploeg EA, Faiz A, Teitsma GJ, Brotons AS, Govorukhina N, Sand JMB, Leeming DJ, Melgert BN, Horvatovich P, Burgess JK, Gan CT.   +10 more
europepmc   +1 more source

Interprofessional and community engagement for evaluating and growing evidence-based criminal justice practice and policy. [PDF]

J Clin Transl Sci, 2023
Bello JK, Jaegers LA.
europepmc   +1 more source